LUNGevityKristin Posted May 14, 2020 Share Posted May 14, 2020 Press Release: GENENTECH TO PRESENT FIRST CLINICAL DATA ON NOVEL ANTI-TIGIT CANCER IMMUNOTHERAPY TIRAGOLUMAB AT ASCO PHASE II CITYSCAPE TRIAL SHOWS PROMISING RESULTS ADDING TIRAGOLUMAB TO TECENTRIQ IN PEOPLE WITH PD-L1-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCERFULL RESULTS WILL BE PRESENTED IN AN ORAL ABSTRACT SESSION AT THE ASCO20 VIRTUAL SCIENTIFIC PROGRAM ORGANIZED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) https://www.gene.com/media/press-releases/14852/2020-05-13/genentech-to-present-first-clinical-data Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.